ROLE OF TISSUE FACTOR IN HEMOSTASIS & THROMBOSIS
组织因子在止血中的作用
基本信息
- 批准号:8147401
- 负责人:
- 金额:$ 30.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2014-06-30
- 项目状态:已结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-KinaseAddressAngiopoietin-1Animal ModelAnti-Inflammatory AgentsAnti-inflammatoryBloodBlood PlateletsBlood VesselsCause of DeathCellsCessation of lifeChoristomaCoagulation ProcessDefectDevelopmentDiseaseDisseminated Intravascular CoagulationEndothelial CellsEndotoxemiaGene ExpressionGeneticGoalsHeartHemostatic AgentsHemostatic functionHumanImmune systemIn VitroInfectionInflammationInflammatoryInstructionInsulinIntensive Care UnitsLeadLungMediatingMediator of activation proteinMusPathway interactionsPatientsPeptide HydrolasesPharmaceutical PreparationsPhenotypePlayProtective AgentsProto-Oncogene Proteins c-aktReducing AgentsRelative (related person)RoleSepsisSourceTestingThromboplastinThrombosisTissuesUnited StatesVascular Endothelial Growth FactorsWound Healingcell typedesignimprovedin vivoinhibitor/antagonistinsightmacrophagemonocytemouse modelnovelnovel therapeuticspathogenprematureresponsetreatment strategy
项目摘要
PROJECT SUMMARY (See instructions):
Tissue factor (TF) is the primary cellular initiator of the coagulation protease cascades. It plays an essential role in hemostasis. Under pathological conditions, however, aberrant TF expression within the vasculature is associated with thrombosis. The goals of this proposal are to determine the roles of TF in hemostasis and thrombosis. In aim 1, we will determine the relative contribution of monocytes, endothelial cells, and platelets to LPS-induced coagulation in a mouse model. Sepsis is the major cause of death in intensive care units in the United States. In humans, the innate immune system has evolved to sense an infection by detecting small amounts of products from the pathogens, such as LPS. However, an excessive response to the presence of LPS in the blood is associated with disseminated intravascular coagulation (DIG).
Monocytes and endothelial cells have been shown to express TF in animal models of endotoxemia and sepsis. More recently, we found that LPS induced TF expression in platelets. In aim 2, we will use both genetic and pharmacologic approaches to investigate the role of the phosphatidylinositol-3-kinase (PI3K)-protein kinase B (Akt) pathway in the suppression of LPS-induced gene expression both in vitro and in vivo.
We have found that the PI3K-Akt pathway suppresses LPS induction of TF and inflammatory gene expression in monocytic cells and in endotoxemic mice. Importantly, several agents that reduce both coagulation and inflammation in animal models of endotoxemia and sepsis activate this pathway. In aim 3, we will investigate the role of the extrinsic (TF and FVII) and intrinsic (FXII, FXI, FIX and FVIII) coagulation pathways in tissue-specific hemostasis and wound healing. A recent study showed that expression of high levels of FVIIa in mice leads to premature death due to thrombosis in the heart and lung. We will cross high FVIIa mice with either low TF mice or mice with increased and decreased TF expression in the heart. The phenotypes of the different mice will test the hypothesis that the extrinsic pathways mediates heart-specific hemostasis.
项目总结(见说明):
组织因子(TF)是凝血蛋白酶级联反应的主要细胞起始因子。它在止血中起着至关重要的作用。然而,在病理条件下,血管系统内异常的TF表达与血栓形成有关。本提案的目的是确定TF在止血和血栓形成中的作用。在目标1中,我们将确定单核细胞、内皮细胞和血小板对小鼠模型中LPS诱导的凝血的相对贡献。败血症是美国重症监护病房的主要死亡原因。在人类中,先天免疫系统已经进化到通过检测来自病原体的少量产物(例如LPS)来感测感染。然而,对血液中存在的LPS的过度反应与弥散性血管内凝血(DIG)相关。
在内毒素血症和脓毒症的动物模型中,单核细胞和内皮细胞已显示表达TF。最近,我们发现LPS诱导血小板TF表达。在目标2中,我们将使用遗传学和药理学方法来研究磷脂酰肌醇-3-激酶(PI 3 K)-蛋白激酶B(Akt)通路在体外和体内LPS诱导的基因表达抑制中的作用。
我们已经发现PI 3 K-Akt通路抑制LPS诱导的TF和单核细胞和内毒素血症小鼠中的炎症基因表达。重要的是,在内毒素血症和脓毒症的动物模型中减少凝血和炎症的几种药物激活了该途径。在目标3中,我们将研究外源性(TF和FVII)和内源性(FXII、FXI、FIX和FVIII)凝血途径在组织特异性止血和伤口愈合中的作用。最近的一项研究表明,小鼠中高水平的FVIIa表达导致由于心脏和肺中的血栓形成而过早死亡。我们将高FVIIa小鼠与低TF小鼠或心脏中TF表达增加和减少的小鼠杂交。不同小鼠的表型将检验外源性途径介导心脏特异性止血的假设。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nigel Mackman其他文献
Nigel Mackman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nigel Mackman', 18)}}的其他基金
Tissue factor-dependent coagulation in thrombosis and immune responses
血栓形成和免疫反应中的组织因子依赖性凝血
- 批准号:
10558720 - 财政年份:2021
- 资助金额:
$ 30.64万 - 项目类别:
Role of the Thrombin PAR-1 Pathway in Viral Infection
凝血酶 PAR-1 途径在病毒感染中的作用
- 批准号:
9380482 - 财政年份:2013
- 资助金额:
$ 30.64万 - 项目类别:
Role of the Thrombin PAR-1 Pathway in Viral Infection
凝血酶 PAR-1 途径在病毒感染中的作用
- 批准号:
8558940 - 财政年份:2013
- 资助金额:
$ 30.64万 - 项目类别:
Role of the Thrombin PAR-1 Pathway in Viral Infection
凝血酶 PAR-1 途径在病毒感染中的作用
- 批准号:
8891487 - 财政年份:2013
- 资助金额:
$ 30.64万 - 项目类别:
Role of the Thrombin PAR-1 Pathway in Viral Infection
凝血酶 PAR-1 途径在病毒感染中的作用
- 批准号:
8706957 - 财政年份:2013
- 资助金额:
$ 30.64万 - 项目类别:
2010 Hemostasis Gordon Research Conference and/or Gordon Research Seminar
2010 止血戈登研究会议和/或戈登研究研讨会
- 批准号:
7911112 - 财政年份:2010
- 资助金额:
$ 30.64万 - 项目类别:
Role of PAR-1 and PAR-2 in Cardiac Remodeling
PAR-1 和 PAR-2 在心脏重构中的作用
- 批准号:
7891220 - 财政年份:2007
- 资助金额:
$ 30.64万 - 项目类别:
Role of PAR-1 and PAR-2 in Cardiac Remodeling
PAR-1 和 PAR-2 在心脏重构中的作用
- 批准号:
7487314 - 财政年份:2007
- 资助金额:
$ 30.64万 - 项目类别:
Role of PAR-1 and PAR-2 in Cardiac Remodeling
PAR-1 和 PAR-2 在心脏重构中的作用
- 批准号:
7666964 - 财政年份:2007
- 资助金额:
$ 30.64万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 30.64万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 30.64万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 30.64万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 30.64万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 30.64万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 30.64万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 30.64万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 30.64万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 30.64万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 30.64万 - 项目类别:
Research Grant














{{item.name}}会员




